DIA Product, News Roundup
Almac’s New Clinical Supply Chain Value-AddTheorem Clinical Research Debuts New BrandingHealthcare Businesswomen’s Association and DIA Form Leadership InitiativeVodafone, Exco InTouch Partners in Patient Reported Outcomes and Patient EngagementPhlexglobal Re-Brands Around TMF ExpertisePAREXEL MyTrials Fully Integrated eClinical Workflow SolutionPharmaNet/i3’s New IRT Release for Randomization, SupplyOracle’s New Version for Translational ResearchDrugDev Survey on Study Start-Up, Site IdentificationTrifecta Multimedical, Web-based Investigator TrainingNew Name, Brand for Clinical Financial ServicesOpen SafeGuard Manages Social Platforms for Potential RiskIntraLinks’ Second Year Global Investigator Site SurveyQuanticate Launches Next Generation Functional Service ProvisionBBK Worldwide Launches Online Patient Recruitment Purchasing PowerMerge eClinical OS, Clinical Trial Operating SolutionComprehend Systems, Analytics in the CloudY-Prime’s Content Review Publishing Tool
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
